Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 10 - 21 save search
Global Industrial Computed Tomography (CT) System market Report 2021 Featuring Nikon Metrology, Waygate Technologies, Wenzel Group, Yxlon International, & Zeiss
Published: 2021-10-21 (Crawled : 20:00) - prnewswire.com
GIC | $40.96 -0.82% 0.0% 57K
|
Retail Trade
|
| O: 0.02%
H: 0.0%
C: -2.09%
trial
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
BCDA P | $0.376 -2.56% 64K
|
Health Technology
|
| O: -1.02%
H: 4.32%
C: 1.38%
therapy trial cardiamp
SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results Published in Clinical Infectious Diseases Demonstrate Significant Superiority of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
SCYX | $1.495 -3.55% -3.68% 88K
|
Health Technology
|
| O: 0.95%
H: 3.58%
C: 2.83%
disease treatment infectious disease results phase 3 trial trial results injection infections
First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis
Published: 2021-10-21 (Crawled : 12:00) - globenewswire.com
FWBI | $3.04 -2.56% -2.63% 37K
|
Manufacturing
|
| O: 3.73%
H: 1.96%
C: -3.27%
phase 2 biopharma cancer trial phase 2b
PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationTemporary administrative suspension of recruitment
Published: 2021-10-21 (Crawled : 12:00) - biospace.com/
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: -3.24%
H: 3.52%
C: -0.69%
phase 2 cancer biotech iot trial
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Published: 2021-10-21 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.6%
H: 0.08%
C: -0.45%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.41%
C: 0.41%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 2.66%
H: 3.69%
C: 3.53%
covid vaccine phase 3 trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.